Candel Therapeutics, Inc. (CADL) › Shares OutstandingCandel Therapeutics, Inc. (CADL) — Shares OutstandingAnnual figures by period end, from SEC filings.2020-12-31: 11.64M2021-12-31: 28.69M2022-12-31: 28.92M2023-12-31: 29.09M2024-12-31: 46.81M2025-12-31: 54.90M54.90M2020-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3154.90M+17.3%2026-03-12Balance as of period end2024-12-3146.81M+60.9%2026-03-12Balance as of period end2023-12-3129.09M+0.6%2025-03-13Balance as of period end2022-12-3128.92M+0.8%2024-03-28Balance as of period end2021-12-3128.69M+146.6%2023-03-30Balance as of period end2020-12-3111.64M—2022-03-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)